2024 ESMO丨方申存教授：肺癌伴软脑膜转移如何安全使用脑室内化疗？曲拉西利带来骨髓保护新进展

文章预览

左右滑动，查看ESMO现场照片 ✩ 本文仅供医疗卫生等专业人士参考 内容审核：nyh 项目审核：李淳 参考文献： [1]Shen Cun Fang，et al. Trilaciclib combined with intraventricular injection chemotherapy in the treatment of advanced NSCLC with leptomeningeal metastasis: A prospective, single-arm, phase II clinical trial.2024 ESMO. 1369P. [2]中国临床肿瘤学会(CSCO) 中西医结合专家委员会.抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识[J].临床肿瘤学杂志,2021,26(11):1020-1027. [3]《中国肿瘤化疗相关骨髓抑制及临床管理现状调研报告（2023年）》. [4]Epstein RS, Aapro MS, Basu Roy UK, et al. Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors. Adv Ther. 2020;37(8):3606-3618. [5]Weiss JM, Csoszi T, Maglakelidze M, et al. Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lun ………………………………